BOLD - Audentes Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.7B
Enterprise Value 31.34B
Trailing P/E N/A
Forward P/E 1-11.24
PEG Ratio (5 yr expected) 1-0.63
Price/Sales (ttm)N/A
Price/Book (mrq)3.83
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-10.25

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-26.23%
Return on Equity (ttm)-42.99%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -131.03M
Net Income Avi to Common (ttm)-128.82M
Diluted EPS (ttm)-3.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)414.31M
Total Cash Per Share (mrq)9.5
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)17.60
Book Value Per Share (mrq)10.17

Cash Flow Statement

Operating Cash Flow (ttm)-107.98M
Levered Free Cash Flow (ttm)-70.81M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.98
52-Week Change 3-1.00%
S&P500 52-Week Change 37.70%
52 Week High 346.18
52 Week Low 317.95
50-Day Moving Average 336.92
200-Day Moving Average 328.35

Share Statistics

Avg Vol (3 month) 3491.93k
Avg Vol (10 day) 3481.6k
Shares Outstanding 543.59M
Float 37.58M
% Held by Insiders 17.46%
% Held by Institutions 1103.43%
Shares Short (Mar 29, 2019) 42.28M
Short Ratio (Mar 29, 2019) 44.21
Short % of Float (Mar 29, 2019) 4N/A
Short % of Shares Outstanding (Mar 29, 2019) 45.24%
Shares Short (prior month Feb 28, 2019) 42.62M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A